3,015
Views
117
CrossRef citations to date
0
Altmetric
Research Paper

DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease

, , &
Pages 366-376 | Received 29 Jun 2013, Accepted 11 Nov 2013, Published online: 19 Nov 2013

References

  • Levey AS, Coresh J. Chronic kidney disease. Lancet 2012; 379:165 - 80; http://dx.doi.org/10.1016/S0140-6736(11)60178-5; PMID: 21840587
  • Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2095 - 128; http://dx.doi.org/10.1016/S0140-6736(12)61728-0; PMID: 23245604
  • McCullough K, Sharma P, Ali T, Khan I, Smith WC, MacLeod A, Black C. Measuring the population burden of chronic kidney disease: a systematic literature review of the estimated prevalence of impaired kidney function. Nephrol Dial Transplant 2012; 27:1812 - 21; http://dx.doi.org/10.1093/ndt/gfr547; PMID: 21965592
  • Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41:1 - 12; http://dx.doi.org/10.1053/ajkd.2003.50007; PMID: 12500213
  • Castledine C, Casula A, Fogarty D. Chapter 2 UK RRT prevalence in 2010: national and centre-specific analyses. Nephron Clin Pract 2012; 120:Suppl 1 c29 - 54; http://dx.doi.org/10.1159/000342844; PMID: 22964573
  • Kerr M, Bray B, Medcalf J, O’Donoghue DJ, Matthews B. Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant 2012; 27:Suppl 3 iii73 - 80; http://dx.doi.org/10.1093/ndt/gfs269; PMID: 22815543
  • Levey AS, Coresh J. Chronic kidney disease. Lancet 2012; 379:165 - 80; http://dx.doi.org/10.1016/S0140-6736(11)60178-5; PMID: 21840587
  • Chasman DI, Fuchsberger C, Pattaro C, Teumer A, Böger CA, Endlich K, Olden M, Chen MH, Tin A, Taliun D, et al, CARDIoGRAM Consortium, ICBP Consortium, CARe Consortium, WTCCC2. Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function. Hum Mol Genet 2012; 21:5329 - 43; http://dx.doi.org/10.1093/hmg/dds369; PMID: 22962313
  • Böger CA, Gorski M, Li M, Hoffmann MM, Huang C, Yang Q, Teumer A, Krane V, O’Seaghdha CM, Kutalik Z, et al, CKDGen Consortium. Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD. PLoS Genet 2011; 7:e1002292; http://dx.doi.org/10.1371/journal.pgen.1002292; PMID: 21980298
  • Sandholm N, Salem RM, McKnight AJ, Brennan EP, Forsblom C, Isakova T, McKay GJ, Williams WW, Sadlier DM, Mäkinen VP, et al, DCCT/EDIC Research Group. New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet 2012; 8:e1002921; http://dx.doi.org/10.1371/journal.pgen.1002921; PMID: 23028342
  • McKnight AJ, Currie D, Maxwell AP. Unravelling the genetic basis of renal diseases; from single gene to multifactorial disorders. J Pathol 2010; 220:198 - 216; PMID: 19882676
  • McKnight AJ, Maxwell AP. Bioinformatic resources for diabetic nephropathy. J Diabetes and Bioinformatics 2013; In press
  • Keller BJ, Martini S, Sedor JR, Kretzler M. A systems view of genetics in chronic kidney disease. Kidney Int 2012; 81:14 - 21; http://dx.doi.org/10.1038/ki.2011.359; PMID: 22012128
  • Dwivedi RS, Herman JG, McCaffrey TA, Raj DS. Beyond genetics: epigenetic code in chronic kidney disease. Kidney Int 2011; 79:23 - 32; http://dx.doi.org/10.1038/ki.2010.335; PMID: 20881938
  • Ekström TJ, Stenvinkel P. The epigenetic conductor: a genomic orchestrator in chronic kidney disease complications?. J Nephrol 2009; 22:442 - 9; PMID: 19662598
  • McCaughan JA, McKnight AJ, Courtney AE, Maxwell AP. Epigenetics: time to translate into transplantation. Transplantation 2012; 94:1 - 7; http://dx.doi.org/10.1097/TP.0b013e31824db9bd; PMID: 22437848
  • Feinberg AP. Epigenetics at the epicenter of modern medicine. JAMA 2008; 299:1345 - 50; http://dx.doi.org/10.1001/jama.299.11.1345; PMID: 18349095
  • Flintoft L. Disease epigenomics: a smoking gun. Nat Rev Genet 2011; 12:300; http://dx.doi.org/10.1038/nrg2991; PMID: 21483458
  • Rakyan VK, Down TA, Balding DJ, Beck S. Epigenome-wide association studies for common human diseases. Nat Rev Genet 2011; 12:529 - 41; http://dx.doi.org/10.1038/nrg3000; PMID: 21747404
  • Dwivedi RS, Herman JG, McCaffrey TA, Raj DS. Beyond genetics: epigenetic code in chronic kidney disease. Kidney Int 2011; 79:23 - 32; http://dx.doi.org/10.1038/ki.2010.335; PMID: 20881938
  • Reddy MA, Natarajan R. Epigenetics in diabetic kidney disease. J Am Soc Nephrol 2011; 22:2182 - 5; http://dx.doi.org/10.1681/ASN.2011060629; PMID: 22021712
  • Chowdhury S, Erickson SW, MacLeod SL, Cleves MA, Hu P, Karim MA, Hobbs CA. Maternal genome-wide DNA methylation patterns and congenital heart defects. PLoS One 2011; 6:e16506; http://dx.doi.org/10.1371/journal.pone.0016506; PMID: 21297937
  • Luttropp K, Lindholm B, Carrero JJ, Glorieux G, Schepers E, Vanholder R, Schalling M, Stenvinkel P, Nordfors L. Genetics/Genomics in chronic kidney disease--towards personalized medicine?. Semin Dial 2009; 22:417 - 22; http://dx.doi.org/10.1111/j.1525-139X.2009.00592.x; PMID: 19708993
  • Joss-Moore LA, Lane RH. Epigenetics and the developmental origins of disease: the key to unlocking the door of personalized medicine. Epigenomics 2012; 4:471 - 3; http://dx.doi.org/10.2217/epi.12.53; PMID: 23130826
  • Liakopoulos V, Georgianos PI, Eleftheriadis T, Sarafidis PA. Epigenetic mechanisms and kidney diseases. Curr Med Chem 2011; 18:1733 - 9; http://dx.doi.org/10.2174/092986711795496827; PMID: 21466478
  • Tsai PC, Spector TD, Bell JT. Using epigenome-wide association scans of DNA methylation in age-related complex human traits. Epigenomics 2012; 4:511 - 26; http://dx.doi.org/10.2217/epi.12.45; PMID: 23130833
  • Syreeni A, El-Osta A, Forsblom C, Sandholm N, Parkkonen M, Tarnow L, Parving HH, McKnight AJ, Maxwell AP, Cooper ME, et al, FinnDiane Study Group. Genetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetes. Diabetes 2011; 60:3073 - 80; http://dx.doi.org/10.2337/db11-0073; PMID: 21896933
  • Bell CG, Teschendorff AE, Rakyan VK, Maxwell AP, Beck S, Savage DA. Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Med Genomics 2010; 3:33; http://dx.doi.org/10.1186/1755-8794-3-33; PMID: 20687937
  • Young GH, Wu VC. KLOTHO methylation is linked to uremic toxins and chronic kidney disease. Kidney Int 2012; 81:611 - 2; http://dx.doi.org/10.1038/ki.2011.461; PMID: 22419041
  • Sapienza C, Lee J, Powell J, Erinle O, Yafai F, Reichert J, Siraj ES, Madaio M. DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy. Epigenetics 2011; 6:20 - 8; http://dx.doi.org/10.4161/epi.6.1.13362; PMID: 21150313
  • Ko YA, Mohtat D, Suzuki M, Park ASD, Izquierdo MC, Han SY, Kang HM, Si H, Hostetter T, Pullman JM, et al. Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development. Genome Biol 2013; 14:R108; http://dx.doi.org/10.1186/gb-2013-14-10-r108; PMID: 24098934
  • Rakyan VK, Down TA, Maslau S, Andrew T, Yang TP, Beyan H, Whittaker P, McCann OT, Finer S, Valdes AM, et al. Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. Genome Res 2010; 20:434 - 9; http://dx.doi.org/10.1101/gr.103101.109; PMID: 20219945
  • Ong ML, Holbrook JD. Novel region discovery method for Infinium 450K DNA methylation data reveals changes associated with aging in muscle and neuronal pathways. Aging Cell 2013; Forthcoming http://dx.doi.org/10.1111/acel.12159; PMID: 24112369
  • Pobribny IP, Vanyushin BF. Age related genomic hypomethylation in epigenetics of aging. Epigenetics of Aging (ed Tollefsbol TO); 2010. ISBN 978—1-4419-0638-0.
  • Reinius LE, Acevedo N, Joerink M, Pershagen G, Dahlén SE, Greco D, Söderhäll C, Scheynius A, Kere J. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One 2012; 7:e41361; http://dx.doi.org/10.1371/journal.pone.0041361; PMID: 22848472
  • Houseman EA, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH, Wiencke JK, Kelsey KT. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics 2012; 13:86; http://dx.doi.org/10.1186/1471-2105-13-86; PMID: 22568884
  • Geisel J, Schorr H, Heine GH, Bodis M, Hübner U, Knapp JP, Herrmann W. Decreased p66Shc promoter methylation in patients with end-stage renal disease. Clin Chem Lab Med 2007; 45:1764 - 70; http://dx.doi.org/10.1515/CCLM.2007.357; PMID: 18067454
  • Stenvinkel P, Karimi M, Johansson S, Axelsson J, Suliman M, Lindholm B, Heimbürger O, Barany P, Alvestrand A, Nordfors L, et al. Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease?. J Intern Med 2007; 261:488 - 99; http://dx.doi.org/10.1111/j.1365-2796.2007.01777.x; PMID: 17444888
  • Hiki Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, Iwase H, Shinzato T, Kobayashi Y, Maeda K. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 2001; 59:1077 - 85; http://dx.doi.org/10.1046/j.1523-1755.2001.0590031077.x; PMID: 11231363
  • Tian E, Ten Hagen KG. Recent insights into the biological roles of mucin-type O-glycosylation. Glycoconj J 2009; 26:325 - 34; http://dx.doi.org/10.1007/s10719-008-9162-4; PMID: 18695988
  • Kakani S, Yardeni T, Poling J, Ciccone C, Niethamer T, Klootwijk ED, Manoli I, Darvish D, Hoogstraten-Miller S, Zerfas P, et al. The Gne M712T mouse as a model for human glomerulopathy. Am J Pathol 2012; 180:1431 - 40; http://dx.doi.org/10.1016/j.ajpath.2011.12.023; PMID: 22322304
  • Alcalay NI, Vanden Heuvel GB. Regulation of cell proliferation and differentiation in the kidney. Front Biosci (Landmark Ed) 2009; 14:4978 - 91; http://dx.doi.org/10.2741/3582; PMID: 19482600
  • Hulea L, Nepveu A. CUX1 transcription factors: from biochemical activities and cell-based assays to mouse models and human diseases. Gene 2012; 497:18 - 26; http://dx.doi.org/10.1016/j.gene.2012.01.039; PMID: 22306263
  • Fragiadaki M, Ikeda T, Witherden A, Mason RM, Abraham D, Bou-Gharios G. High doses of TGF-β potently suppress type I collagen via the transcription factor CUX1. Mol Biol Cell 2011; 22:1836 - 44; http://dx.doi.org/10.1091/mbc.E10-08-0669; PMID: 21471005
  • Shimazaki A, Kawamura Y, Kanazawa A, Sekine A, Saito S, Tsunoda T, Koya D, Babazono T, Tanaka Y, Matsuda M, et al. Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy. Diabetes 2005; 54:1171 - 8; http://dx.doi.org/10.2337/diabetes.54.4.1171; PMID: 15793258
  • Hanson RL, Millis MP, Young NJ, Kobes S, Nelson RG, Knowler WC, DiStefano JK. ELMO1 variants and susceptibility to diabetic nephropathy in American Indians. Mol Genet Metab 2010; 101:383 - 90; http://dx.doi.org/10.1016/j.ymgme.2010.08.014; PMID: 20826100
  • Shimazaki A, Tanaka Y, Shinosaki T, Ikeda M, Watada H, Hirose T, Kawamori R, Maeda S. ELMO1 increases expression of extracellular matrix proteins and inhibits cell adhesion to ECMs. Kidney Int 2006; 70:1769 - 76; http://dx.doi.org/10.1038/sj.ki.5001939; PMID: 17021600
  • Yang C, Sorokin A. Upregulation of fibronectin expression by COX-2 is mediated by interaction with ELMO1. Cell Signal 2011; 23:99 - 104; http://dx.doi.org/10.1016/j.cellsig.2010.08.008; PMID: 20732417
  • Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM, Pace TW, Mercer KB, Mayberg HS, Bradley B, et al. Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci 2013; 16:33 - 41; http://dx.doi.org/10.1038/nn.3275; PMID: 23201972
  • Grigoryev DN, Liu M, Cheadle C, Barnes KC, Rabb H. Genomic profiling of kidney ischemia-reperfusion reveals expression of specific alloimmunity-associated genes: Linking “immune” and “nonimmune” injury events. Transplant Proc 2006; 38:3333 - 6; http://dx.doi.org/10.1016/j.transproceed.2006.10.129; PMID: 17175265
  • Happé H, van der Wal AM, Leonhard WN, Kunnen SJ, Breuning MH, de Heer E, Peters DJ. Altered Hippo signalling in polycystic kidney disease. J Pathol 2011; 224:133 - 42; http://dx.doi.org/10.1002/path.2856; PMID: 21381034
  • Famulski KS, Sis B, Billesberger L, Halloran PF. Interferon-gamma and donor MHC class I control alternative macrophage activation and activin expression in rejecting kidney allografts: a shift in the Th1-Th2 paradigm. Am J Transplant 2008; 8:547 - 56; http://dx.doi.org/10.1111/j.1600-6143.2007.02118.x; PMID: 18294151
  • Garrett SH, Clarke K, Sens DA, Deng Y, Somji S, Zhang KK. Short and long term gene expression variation and networking in human proximal tubule cells when exposed to cadmium. BMC Med Genomics 2013; 6:Suppl 1 S2; http://dx.doi.org/10.1186/1755-8794-6-S1-S2; PMID: 23369406
  • Wen J, Ji ZG, Niu JR. [Regulatory effects of cyclosporin a and tacrolimus on th immunological gene expressions in renal transplant recipients]. [Abstract only] Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2012; 34:563 - 6; PMID: 23286399
  • Böger CA, Gorski M, Li M, Hoffmann MM, Huang C, Yang Q, Teumer A, Krane V, O’Seaghdha CM, Kutalik Z, et al, CKDGen Consortium. Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD. PLoS Genet 2011; 7:e1002292; http://dx.doi.org/10.1371/journal.pgen.1002292; PMID: 21980298
  • Köttgen A, Pattaro C, Böger CA, Fuchsberger C, Olden M, Glazer NL, Parsa A, Gao X, Yang Q, Smith AV, et al. New loci associated with kidney function and chronic kidney disease. Nat Genet 2010; 42:376 - 84; http://dx.doi.org/10.1038/ng.568; PMID: 20383146
  • Wasmeier C, Hutton JC. Molecular cloning of phogrin, a protein-tyrosine phosphatase homologue localized to insulin secretory granule membranes. J Biol Chem 1996; 271:18161 - 70; http://dx.doi.org/10.1074/jbc.271.30.18161; PMID: 8663434
  • Kawasaki E, Hutton JC, Eisenbarth GS. Molecular cloning and characterization of the human transmembrane protein tyrosine phosphatase homologue, phogrin, an autoantigen of type 1 diabetes. Biochem Biophys Res Commun 1996; 227:440 - 7; http://dx.doi.org/10.1006/bbrc.1996.1526; PMID: 8878534
  • Yoshida T, Kato K, Yokoi K, Oguri M, Watanabe S, Metoki N, Yoshida H, Satoh K, Aoyagi Y, Nozawa Y, et al. Association of genetic variants with chronic kidney disease in Japanese individuals with or without hypertension or diabetes mellitus. Exp Ther Med 2010; 1:137 - 45; PMID: 23136606
  • Rakyan VK, Beyan H, Down TA, Hawa MI, Maslau S, Aden D, Daunay A, Busato F, Mein CA, Manfras B, et al. Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis. PLoS Genet 2011; 7:e1002300; http://dx.doi.org/10.1371/journal.pgen.1002300; PMID: 21980303
  • Philibert RA, Plume JM, Gibbons FX, Brody GH, Beach SR. The impact of recent alcohol use on genome wide DNA methylation signatures. Front Genet 2012; 3:54; http://dx.doi.org/10.3389/fgene.2012.00054; PMID: 22514556
  • Breitling LP, Yang R, Korn B, Burwinkel B, Brenner H. Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet 2011; 88:450 - 7; http://dx.doi.org/10.1016/j.ajhg.2011.03.003; PMID: 21457905
  • Nakano K, Whitaker JW, Boyle DL, Wang W, Firestein GS. DNA methylome signature in rheumatoid arthritis. Ann Rheum Dis 2013; 73:110 - 7; http://dx.doi.org/10.1136/annrheumdis-2012-201526; PMID: 22736089
  • Harris RA, Nagy-Szakal D, Pedersen N, Opekun A, Bronsky J, Munkholm P, Jespersgaard C, Andersen P, Melegh B, Ferry G, et al. Genome-wide peripheral blood leukocyte DNA methylation microarrays identified a single association with inflammatory bowel diseases. Inflamm Bowel Dis 2012; 18:2334 - 41; http://dx.doi.org/10.1002/ibd.22956; PMID: 22467598
  • Bechtel W, McGoohan S, Zeisberg EM, Müller GA, Kalbacher H, Salant DJ, Müller CA, Kalluri R, Zeisberg M. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med 2010; 16:544 - 50; http://dx.doi.org/10.1038/nm.2135; PMID: 20418885
  • Woroniecki R, Gaikwad AB, Susztak K. Fetal environment, epigenetics, and pediatric renal disease. Pediatr Nephrol 2011; 26:705 - 11; http://dx.doi.org/10.1007/s00467-010-1714-8; PMID: 21174217
  • Flintoft L. Disease epigenomics: a smoking gun. Nat Rev Genet 2011; 12:300; http://dx.doi.org/10.1038/nrg2991; PMID: 21483458
  • Harris RA, Nagy-Szakal D, Pedersen N, Opekun A, Bronsky J, Munkholm P, Jespersgaard C, Andersen P, Melegh B, Ferry G, et al. Genome-wide peripheral blood leukocyte DNA methylation microarrays identified a single association with inflammatory bowel diseases. Inflamm Bowel Dis 2012; 18:2334 - 41; http://dx.doi.org/10.1002/ibd.22956; PMID: 22467598
  • Zhu Y, Stevens RG, Hoffman AE, Tjonneland A, Vogel UB, Zheng T, Hansen J. Epigenetic impact of long-term shiftwork: pilot evidence from circadian genes and whole-genome methylation analysis. Chronobiol Int 2011; 28:852 - 61; http://dx.doi.org/10.3109/07420528.2011.618896; PMID: 22080730
  • Wang L, Aakre JA, Jiang R, Marks RS, Wu Y, Chen J, Thibodeau SN, Pankratz VS, Yang P. Methylation markers for small cell lung cancer in peripheral blood leukocyte DNA. J Thorac Oncol 2010; 5:778 - 85; http://dx.doi.org/10.1097/JTO.0b013e3181d6e0b3; PMID: 20421821
  • McCaughan JA, Courtney AE, Maxwell AP, McKnight AJ. Genome wide methylation analysis of 485,577 features in a renal transplant population. J Am Soc Nephrol 2011; 22:458A
  • Sapari NS, Loh M, Vaithilingam A, Soong R. Clinical potential of DNA methylation in gastric cancer: a meta-analysis. PLoS One 2012; 7:e36275; http://dx.doi.org/10.1371/journal.pone.0036275; PMID: 22558417
  • Woo HD, Kim J. Global DNA hypomethylation in peripheral blood leukocytes as a biomarker for cancer risk: a meta-analysis. PLoS One 2012; 7:e34615; http://dx.doi.org/10.1371/journal.pone.0034615; PMID: 22509334
  • Black C, Sharma P, Scotland G, McCullough K, McGurn D, Robertson L, Fluck N, MacLeod A, McNamee P, Prescott G, et al. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess 2010; 14:1 - 184; PMID: 20441712
  • Sandoval J, Heyn H, Moran S, Serra-Musach J, Pujana MA, Bibikova M, Esteller M. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 2011; 6:692 - 702; http://dx.doi.org/10.4161/epi.6.6.16196; PMID: 21593595
  • Kauffmann A, Huber W. Microarray data quality control improves the detection of differentially expressed genes. Genomics 2010; 95:138 - 42; http://dx.doi.org/10.1016/j.ygeno.2010.01.003; PMID: 20079422
  • Smyth G. Limma: linear models for microarray data in Bioinformatics and Computational Biology Solutions using R and Bioconductor 397-420. Springer, New York (2005).
  • Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc, B 1995; 57:289 - 300
  • Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C, et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 2013; 41:D808 - 15; http://dx.doi.org/10.1093/nar/gks1094; PMID: 23203871
  • NCBI Resource Coordinators. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2013; 41:D8 - 20; http://dx.doi.org/10.1093/nar/gks1189; PMID: 23193264
  • McKnight AJ, Woodman AM, Parkkonen M, Patterson CC, Savage DA, Forsblom C, Pettigrew KA, Sadlier D, Groop PH, Maxwell AP, Warren 3/UK GoKinD Study Group. Investigation of DNA polymorphisms in SMAD genes for genetic predisposition to diabetic nephropathy in patients with type 1 diabetes mellitus. Diabetologia 2009; 52:844 - 9; http://dx.doi.org/10.1007/s00125-009-1281-3; PMID: 19247629

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.